Healthcare provider profile · identity verified

Keith S Garb, M.D.

Internal Medicine · CALABASAS, CA · NPI 1740381177

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	574	188
Amlodipine Besylate	Amlodipine Besylate	471	137
Pravastatin Sodium	Pravastatin Sodium	299	93
Rosuvastatin Calcium	Rosuvastatin Calcium	280	87
Losartan Potassium	Losartan Potassium	234	72
Levothyroxine Sodium	Levothyroxine Sodium	204	68
Tamsulosin Hcl	Tamsulosin Hcl	160	52
Lisinopril	Lisinopril	151	52
Simvastatin	Simvastatin	150	48
Alprazolam	Alprazolam	149	53
Pantoprazole Sodium	Pantoprazole Sodium	144	52
Trazodone Hcl	Trazodone Hcl	140	42
Metoprolol Succinate	Metoprolol Succinate	136	39
Albuterol Sulfate Hfa	Albuterol Sulfate	128	59
Zolpidem Tartrate	Zolpidem Tartrate	116	36
Metformin Hcl	Metformin Hcl	114	34
Escitalopram Oxalate	Escitalopram Oxalate	109	32
Montelukast Sodium	Montelukast Sodium	99	30
Hydrochlorothiazide	Hydrochlorothiazide	98	36
Sertraline Hcl	Sertraline Hcl	94	28
Gabapentin	Gabapentin	92	40
Lorazepam	Lorazepam	81	22
Meloxicam	Meloxicam	78	42
Omeprazole	Omeprazole	78	27
Valacyclovir	Valacyclovir Hcl	72	37
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	71	22
Wixela Inhub	Fluticasone Propion/Salmeterol	66	26
Famotidine	Famotidine	63	22
Tramadol Hcl	Tramadol Hcl	62	24
Metformin Hcl Er	Metformin Hcl	61	22
Azithromycin	Azithromycin	60	50
Fluticasone Propionate	Fluticasone Propionate	60	31
Allopurinol	Allopurinol	57	17
Synthroid	Levothyroxine Sodium	57	24
Finasteride	Finasteride	53	21
Ibuprofen	Ibuprofen	52	16
Celecoxib	Celecoxib	49	12
Clonazepam	Clonazepam	49	suppressed
Ipratropium Bromide	Ipratropium Bromide	49	23
Clopidogrel	Clopidogrel Bisulfate	46	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	45	14
Breo Ellipta	Fluticasone/Vilanterol	42	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	42	15
Mounjaro	Tirzepatide	38	suppressed
Temazepam	Temazepam	38	11
Bupropion Xl	Bupropion Hcl	36	13
Duloxetine Hcl	Duloxetine Hcl	36	11
Ezetimibe	Ezetimibe	35	16
Furosemide	Furosemide	34	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	33	16
Xarelto	Rivaroxaban	33	suppressed
Buspirone Hcl	Buspirone Hcl	32	suppressed
Carisoprodol	Carisoprodol	32	11
Jardiance	Empagliflozin	32	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	14
Olmesartan Medoxomil	Olmesartan Medoxomil	31	11
Diclofenac Sodium	Diclofenac Sodium	30	suppressed
Potassium Chloride	Potassium Chloride	30	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	24
Zaleplon	Zaleplon	28	suppressed
Atenolol	Atenolol	27	suppressed
Estradiol	Estradiol	27	12
Ozempic	Semaglutide	27	suppressed
Eliquis	Apixaban	26	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Prednisone	Prednisone	24	15
Spironolactone	Spironolactone	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Azelastine Hcl	Azelastine Hcl	23	suppressed
Methylprednisolone	Methylprednisolone	23	21
Carvedilol	Carvedilol	22	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Dutasteride	Dutasteride	22	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	21	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	21	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Baclofen	Baclofen	19	suppressed
Glimepiride	Glimepiride	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Ibandronate Sodium	Ibandronate Sodium	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Testosterone	Testosterone	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Movantik	Naloxegol Oxalate	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	11
Valsartan	Valsartan	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	11
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Potassium Citrate Er	Potassium Citrate	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Cephalexin	Cephalexin	12	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Linzess	Linaclotide	12	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Qnasl	Beclomethasone Dipropionate	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Citalopram Hbr	Citalopram Hydrobromide	11	suppressed
Diazepam	Diazepam	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Ramipril	Ramipril	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error